A Study to Evaluate Surgical Sterility, the Microbiome and Infections Following Mastectomy with Immediate / Tissue Expander Reconstruction

Overview

About this study

The purpose of this study is to evaluate surgical sterility, the microbiome, and infections post mastectomy with immediate/tissue expander surgery by using OR camera recording, surgical site and/or microbiome analysis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Female patients age 18 years and greater.
Willing and able to give informed consent.
Mastectomy with immediate reconstruction using tissue expander or direct to implant.

Exclusion Criteria:

Antibiotic use within 14 days of operation.
Prior history of breast implant placement.
Male patients.
Vulnerable subjects (prisoners, institutionalized individuals).
Non-English speaking patients without adequate interpreter assistance.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Basel Sharaf, M.D., D.D.S.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Basel Sharaf, M.D., D.D.S.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials